The Flavone Luteolin Suppresses SREBP-2 Expression and Post-Translational Activation in Hepatic Cells.

A decreasing trend in the cellular cholesterol levels was observed in WRL-68 cells ( Fig 10A ) or HepG2 cells ( Fig 10B ) under luteolin treatment.

also in 47,180 other papers

The ratio displayed an increasing trend as the concentration of luteolin administered increased ( Fig 11B ) with the reduction of the ATP concentration ( Fig 11C )( Table B in S11 Dataset ).

also in 63,971 other papers